Europe PMC
Nothing Special   »   [go: up one dir, main page]

Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

FDA approves ADC Therapeutics' loncastuximab tesirine, ushering in a new cytotoxic payload.

Nature reviews. Drug Discovery, 01 Jun 2021, 20(6):414
https://doi.org/10.1038/d41573-021-00082-y PMID: 33981088 

Abstract 

No abstract provided.

Full text links 

Read article at publisher's site: https://doi.org/10.1038/d41573-021-00082-y

Citations & impact 

Impact metrics

5
Citations
Jump to Citations

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/105837462
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/105837462

Smart citations by scite.ai
Smart citations by scite.ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by EuropePMC if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.
Explore citation contexts and check if this article has been supported or disputed.
https://scite.ai/reports/10.1038/d41573-021-00082-y

Supporting
Mentioning
Contrasting
0
6
0

Article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.